Science Advances,
Journal Year:
2024,
Volume and Issue:
10(36)
Published: Sept. 6, 2024
Functional
assays
on
intact
tumor
biopsies
can
complement
genomics-based
approaches
for
precision
oncology,
drug
testing,
and
organs-on-chips
cancer
disease
models
by
capturing
key
therapeutic
response
determinants,
such
as
tissue
architecture,
heterogeneity,
the
microenvironment.
Most
of
these
rely
fluorescent
labeling,
a
semiquantitative
method
best
suited
single-time-point
or
labor-intensive
immunostaining
analysis.
Here,
we
report
integrated
aptamer
electrochemical
sensors
on-chip,
real-time
monitoring
cytochrome
C,
cell
death
indicator,
from
microdissected
tissues
with
high
affinity
specificity.
The
platform
features
multi-well
sensor
layout
multiplexed
electronic
setup.
aptasensors
measure
increases
in
C
supernatant
mouse
human
tumors
after
exposure
to
various
treatments.
Because
sensor’s
affinity,
it
primarily
tracks
rising
concentrations
dynamic
changes
during
apoptosis.
This
approach
could
help
develop
more
advanced
apply
other
complex
vitro
models,
organoids.
Advanced Materials,
Journal Year:
2023,
Volume and Issue:
36(34)
Published: Sept. 22, 2023
Additive
manufacturing
(AM),
which
is
based
on
the
principle
of
layer-by-layer
shaping
and
stacking
discrete
materials,
has
shown
significant
benefits
in
fabrication
complicated
implants
for
tissue
engineering
(TE).
However,
many
native
tissues
exhibit
anisotropic
heterogenous
constructs
with
diverse
components
functions.
Consequently,
replication
biomimetic
using
conventional
AM
processes
a
single
material
challenging.
Multimaterial
3D
4D
bioprinting
(with
time
as
fourth
dimension)
emerged
promising
solution
constructing
multifunctional
that
can
mimic
host
microenvironment
better
than
single-material
alternatives.
Notably,
4D-printed
multimaterial
architectures
provide
time-dependent
programmable
dynamic
promote
cell
activity
regeneration
response
to
external
stimuli.
This
paper
first
presents
typical
design
strategies
TE
applications.
Subsequently,
latest
are
discussed,
along
their
advantages
challenges.
In
particular,
potential
smart
highlighted.
Furthermore,
this
review
provides
insights
into
how
facilitate
realization
next-generation
ACS Sensors,
Journal Year:
2024,
Volume and Issue:
9(7), P. 3466 - 3488
Published: July 11, 2024
Organ-on-a-Chip
(OOC)
technology,
which
emulates
the
physiological
environment
and
functionality
of
human
organs
on
a
microfluidic
chip,
is
undergoing
significant
technological
advancements.
Despite
its
rapid
evolution,
this
technology
also
facing
notable
challenges,
such
as
lack
vascularization,
development
multiorgan-on-a-chip
systems,
replication
body
single
chip.
The
progress
has
played
crucial
role
in
steering
OOC
toward
mimicking
microenvironment,
including
microenvironment
replication,
multiorgan
microphysiological
systems.
Additionally,
advancements
detection,
analysis,
organoid
imaging
technologies
have
enhanced
efficiency
Organs-on-Chips
(OOCs).
In
particular,
integration
artificial
intelligence
revolutionized
imaging,
significantly
enhancing
high-throughput
drug
screening.
Consequently,
review
covers
research
Human-on-a-chip,
sensors
OOCs,
latest
applications
biomedical
field.
Bioactive Materials,
Journal Year:
2024,
Volume and Issue:
42, P. 140 - 164
Published: Aug. 30, 2024
As
a
powerful
paradigm,
artificial
intelligence
(AI)
is
rapidly
impacting
every
aspect
of
our
day-to-day
life
and
scientific
research
through
interdisciplinary
transformations.
Living
human
organoids
(LOs)
have
great
potential
for
Chinese Medical Journal,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 25, 2025
Abstract
The
high
failure
rates
in
clinical
drug
development
based
on
animal
models
highlight
the
urgent
need
for
more
representative
human
biomedical
research.
In
response
to
this
demand,
organoids
and
organ
chips
were
integrated
greater
physiological
relevance
dynamic,
controlled
experimental
conditions.
This
innovative
platform—the
organoids-on-a-chip
technology—shows
great
promise
disease
modeling,
discovery,
personalized
medicine,
attracting
interest
from
researchers,
clinicians,
regulatory
authorities,
industry
stakeholders.
review
traces
evolution
organoids-on-a-chip,
driven
by
necessity
advanced
biological
models.
We
summarize
applications
of
simulating
pathological
phenotypes
therapeutic
evaluation
technology.
section
highlights
how
integrating
technologies
chips,
such
as
microfluidic
systems,
mechanical
stimulation,
sensor
integration,
optimizes
organoid
cell
types,
spatial
structure,
functions,
thereby
expanding
their
applications.
conclude
addressing
current
challenges
offering
insights
into
prospects.
advancement
is
poised
enhance
fidelity,
standardization,
scalability.
Furthermore,
integration
cutting-edge
interdisciplinary
collaborations
will
be
crucial
progression
ACS Omega,
Journal Year:
2024,
Volume and Issue:
9(12), P. 13534 - 13555
Published: March 7, 2024
Pulmonary
diseases
like
asthma,
chronic
obstructive
pulmonary
disorder,
lung
fibrosis,
and
cancer
pose
a
significant
burden
to
global
human
health.
Many
of
these
complications
arise
as
result
exposure
particulate
matter
(PM),
which
has
been
examined
in
several
preclinical
clinical
trials
for
its
effect
on
respiratory
diseases.
Particulate
size
less
than
2.5
μm
(PM2.5)
known
inflict
unforeseen
repercussions,
although
data
from
epidemiological
studies
back
this
are
pending.
Conventionally
utilized
two-dimensional
(2D)
cell
culture
animal
models
have
provided
insufficient
benefits
emulating
the
vivo
physiological
pathological
conditions.
Three-dimensional
(3D)
structural
models,
including
organ-on-a-chip
experienced
developmental
upsurge
recent
times.
Lung-on-a-chip
potential
simulate
specific
features
lungs.
With
advancement
technology,
an
emerging
advanced
technique
termed
microfluidic
developed
with
aim
identifying
complexity
cellular
microenvironment
body.
In
present
Review,
role
lung-on-a-chip
modeling
reproducing
explored,
emphasis
PM2.5-induced
complications.
Biosensors,
Journal Year:
2023,
Volume and Issue:
13(10), P. 905 - 905
Published: Sept. 24, 2023
The
increasing
popularity
of
3D
cell
culture
models
is
being
driven
by
the
demand
for
more
in
vivo-like
conditions
with
which
to
study
biochemistry
and
biomechanics
numerous
biological
processes
health
disease.
Spheroids
organoids
are
platforms
that
self-assemble
regenerate
from
stem
cells,
tissue
progenitor
cells
or
lines,
show
great
potential
studying
development
regeneration.
Organ-on-a-chip
approaches
can
be
used
achieve
spatiotemporal
control
over
biochemical
biomechanical
signals
promote
growth
differentiation.
These
model
systems
engineered
serve
as
disease
drug
screens.
While
methods
have
been
developed
support
these
structures,
challenges
remain
completely
recapitulate
cell–cell
cell–matrix
interactions
occurring
vivo.
Understanding
how
forces
influence
functions
will
require
precise
tools
measure
such
forces,
well
a
better
understanding
mechanobiology
interactions.
Biosensors
prove
powerful
measuring
both
contexts,
thereby
leading
mechanical
at
cellular
levels.
Here,
we
discussed
biosensors
mechanobiological
research
coupled
develop
accurate,
physiologically
relevant
development,
function,
malfunction
disease,
avenues
intervention.